Literature DB >> 24041473

Mathematical models: a key to understanding HIV envelope interactions?

Carsten Magnus1, Oliver F Brandenberg, Peter Rusert, Alexandra Trkola, Roland R Regoes.   

Abstract

The spikes of the human immunodeficiency virus (HIV) mediate viral entry and are the most important targets for neutralizing antibodies. Each spike consists of three identical subunits. The role of the spike's subunits in antibody binding is not fully understood. One experimental approach to analyze trimer function uses assays with mixed envelope trimer expressing cells or viruses. As these experiments do not allow direct observation of subunit functions, mathematical models are required to interpret them. Here we describe a modeling framework to study (i) the interaction of the V1V2 loop with epitopes on the V3 loop and (ii) the composition of quaternary epitopes. In a first step we identify which trimers can form in these assays and how they function under antibody binding. We then derive the behavior of an average trimer. We contrast two experimental reporting systems and list their advantages and disadvantages. In these experiments trimer formation might not be perfectly random and we show how these effects can be tested. As we still lack a potent vaccine against HIV, and this vaccine surely has to stimulate the production of neutralizing antibodies, mixed trimer approaches in combination with mathematical models will help to identify vulnerable sites of the HIV spike.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epitope masking by variable loops 1 and 2; Human immunodeficiency virus envelope interactions; Mathematical models; Quaternary epitopes

Mesh:

Substances:

Year:  2013        PMID: 24041473     DOI: 10.1016/j.jim.2013.09.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

Review 1.  Molecular determinants of the ratio of inert to infectious virus particles.

Authors:  P J Klasse
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

2.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09

3.  Mathematical model of multivalent virus-antibody complex formation in humans following acute and chronic HIV infections.

Authors:  Stanca M Ciupe
Journal:  J Math Biol       Date:  2014-09-05       Impact factor: 2.259

4.  Estimating treatment prolongation for persistent infections.

Authors:  Antal Martinecz; Pia Abel Zur Wiesch
Journal:  Pathog Dis       Date:  2018-08-01       Impact factor: 3.166

5.  Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry.

Authors:  Oliver F Brandenberg; Carsten Magnus; Peter Rusert; Roland R Regoes; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

6.  Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.

Authors:  Oliver F Brandenberg; Carsten Magnus; Peter Rusert; Huldrych F Günthard; Roland R Regoes; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2017-05-04       Impact factor: 6.823

7.  Estimated secondary structure propensities within V1/V2 region of HIV gp120 are an important global antibody neutralization sensitivity determinant.

Authors:  Maxim Totrov
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.